Search

everythinglearnresearchcommunity

for

Search:↓

PCOS affects many women, causing various symptoms and health risks, and is managed through lifestyle changes, medication, and support groups.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Lithium can cause skin issues like acne and hair loss.

Acne and hair loss are not good indicators of hormone imbalance in PCOS, but excessive body hair is.

Testosterone therapy in transgender men can cause acne.

Acne and hidradenitis suppurativa have different causes and risk factors, but both are driven by inflammation and may benefit from treatments targeting interleukin-1.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Hormonal imbalances in congenital adrenal hyperplasia cause acne.

Precise skin sampling is crucial to understand the role of P. acnes in acne.

Vitamin C-based nanovesicles effectively treat acne.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Stress can worsen skin conditions and affect mental health, so doctors should include stress management in skin treatment.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

PCOD mainly affects young women, causing symptoms like irregular periods and weight gain, with mixed success from lifestyle changes and medication.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

Ivermectin with supportive therapies effectively treats canine demodicosis.

Eating junk food is linked to higher rates of PCOS and related symptoms in women.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.